Android app on Google Play

Lazard Capital Starts Nektar Therapeutics (NKTR) at Buy

January 15, 2013 6:44 AM EST Send to a Friend
Get Alerts NKTR Hot Sheet
Price: $10.98 -0.27%

Rating Summary:
    7 Buy, 1 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 38 | New: 6
Trade NKTR Now!
Join SI Premium – FREE
Lazard Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $15.00.

For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.

Shares of Nektar Therapeutics closed at $8.74 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Lazard

Add Your Comment